Back
Charles River Laboratories International 10K Form
Sell
43
CRL
Charles River Laboratories International
Last Price:
195.80
Seasonality Move:
9.91%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | CRL/Charles River Laboratories International Quarterly |
| 2023-08-09 | 10Q | CRL/Charles River Laboratories International Quarterly |
| 2023-05-11 | 10Q | CRL/Charles River Laboratories International Quarterly |
| 2022-11-02 | 10Q | CRL/Charles River Laboratories International Quarterly |
| 2022-08-03 | 10Q | CRL/Charles River Laboratories International Quarterly |
| 2022-05-04 | 10Q | CRL/Charles River Laboratories International Quarterly |
Receive CRL News And Ratings
See the #1 stock for the next 7 days that we like better than CRL
CRL Financial Statistics
Sales & Book Value
| Annual Sales: | $4.13B |
|---|---|
| Cash Flow: | $213.07M |
| Price / Cash Flow: | 18.04 |
| Annual Sales: | $73.97 |
| Price / Book: | 2.65 |
Profitability
| EPS (TTM): | 8.01000 |
|---|---|
| Net Income (TTM): | $413.08M |
| Gross Margin: | $1.5B |
| Return on Equity: | 11.28% |
| Return on Assets: | 5.18% |
Charles River Laboratories International Earnings Forecast
Key Charles River Laboratories International Financial Ratios
- The Gross Profit Margin over the past 26 years for CRL is 36.39%.
- The Selling, General & Administrative Expenses for CRL have been equal to 18.11% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 28.80% of Operating Income.
- The Net Earning history of CRL is 11.49% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 17 years.
Charles River Laboratories International Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | CRL |
| CUSIP: | 159864 |
| Website: | criver.com |
Debt
| Debt-to-Equity Ratio: | 0.62 |
|---|---|
| Current Ratio: | 1.48 |
| Quick Ratio: | 0.95 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.23 |
|---|---|
| Forward P/E Ratio: | 18.98 |
CRL Technical Analysis vs Fundamental Analysis
Sell
43
Charles River Laboratories International (CRL)
is a Sell
Is Charles River Laboratories International a Buy or a Sell?
-
Charles River Laboratories International stock is rated a Sell
The current Charles River Laboratories International [CRL] share price is $195.77. The Score for CRL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.